• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Ubiquitin carboxyl-terminal hydrolase 40 (USP40), Truncated

ACP10898

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10898 Target NameUSP40
Target SynonymsDeubiquitinating enzyme 40; Ubiquitin carboxyl-terminal hydrolase 40; Ubiquitin thiolesterase 40; Ubiquitin-specific-processing protease 40; UBP40_HUMAN; Usp40FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9NVE5
Background Information
  • Uniprot Id

    Q9NVE5

  • Target Species

    Human

  • Target Name

    USP40

  • Target Full Name

    Ubiquitin carboxyl-terminal hydrolase 40

  • Target Function

    May be catalytically inactive.

  • Target Protein Families

    Peptidase C19 family

  • Target Tissue Specificity

    Broadly expressed.

  • Target Synonyms

    Deubiquitinating enzyme 40; Ubiquitin carboxyl-terminal hydrolase 40; Ubiquitin thiolesterase 40; Ubiquitin-specific-processing protease 40; UBP40_HUMAN; Usp40

  • Target Background

    Modification of cellular proteins by ubiquitin is an essential regulatory mechanism controlled by the coordinated action of multiple ubiquitin-conjugating and deubiquitinating enzymes. USP40 belongs to a large family of cysteine proteases that function as deubiquitinating enzymes (Quesada et al., 2004 [PubMed 14715245]).

Inquire Recombinant Human Ubiquitin carboxyl-terminal hydrolase 40 (USP40), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification